Results 71 to 80 of about 19,007 (183)

Hypophosphatemic rickets: A case of recurrent pathological fractures

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Introduction: Renal phosphate-wasting disorders are the most common form of hereditary rickets and osteomalacia in western countries, but are rarely reported in India. Therefore, we report here a case of hypophosphatemic rickets.
Arjun Baidya   +3 more
doaj   +1 more source

Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?

open access: yesIndian Journal of Radiology and Imaging, 2017
The somatostatin (SS) receptor scintigraphy (SRS), using octreotide radiolabelled with 111In (Ocreoscan©, OCT), is a consolidated diagnostic procedure in patients with neuroendocrine tumors (NET) because of an increased expression of somatostatin ...
Vincenzo Cuccurullo   +3 more
doaj   +1 more source

Osteomalacia [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1969
C K, Connolly, J R, Nassim
openaire   +2 more sources

Oncogenous osteomalacia

open access: yesJournal of Cancer Research and Therapeutics, 2009
Oncogenous osteomalacia is a rare paraneoplastic renal phosphaturic condition, often associated with highly vascular benign mesenchymal tumors. We report a case of a 48-year-old male who presented with debilitating osteomalacia unresponsive to standard therapy.
Ghosh, Soumitra   +3 more
openaire   +2 more sources

Familial vitamin D deficient osteomalacia and renal osteodystrophy: Shaping up the debate

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2010
Osteomalacia is a common occurrence world over due to the deficiency in vitamin D and calcium intake. We present here two sisters with features of sever osteomalacia, myopathy and hypophosphatemia hyperparathryroidism and 25(OH)D2, 25(OH)D3and 1,25(OH)D3
Jabur Wael
doaj  

Case Report: Phosphaturic mesenchymal tumor presenting solely as knee pain without hypophosphatemia

open access: yesFrontiers in Oncology
Phosphaturic mesenchymal tumor (PMT) is a rare tumor disease that often leads to tumor-induced osteomalacia (TIO). The typical manifestations of this disease include hypophosphatemia and osteomalacia. The main symptom in most PMT patients is diffuse pain
Qianqian Cao, Cheng Cheng, Zhipeng Dai
doaj   +1 more source

Tumor-induced phosphopenic osteomalacia: modern approaches to diagnostics and treatment

open access: yesСовременная ревматология
Phosphopenic osteomalacia (PPOM) is a rare variant of paraneoplastic syndrome caused by tumor synthesis of fibroblast growth factor 23 (FGF23). FGF23 secretion leads to a decrease in phosphate reabsorption and calcitriol levels, which leads to the ...
A. A. Kondrashov   +4 more
doaj   +1 more source

An unusual cause of osteomalacia in a young lady

open access: yesAnnals of Medical Science and Research
Oncogenic osteomalacia is a rare entity, caused by excessive secretion of fibroblast growth factor-23 (FGF-23) from the peripherally located benign tumours of mesenchymal origin.
Angan Karmakar   +3 more
doaj   +1 more source

Oncogenic osteomalacia [PDF]

open access: yesQJM: An International Journal of Medicine, 2018
Annamalai, AK   +14 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy